7 Amendments of Viorica DĂNCILĂ related to 2016/2096(INI)
Amendment 28 #
Motion for a resolution
Recital B a (new)
Recital B a (new)
Ba. whereas austerity measures have had a more pronounced effect on women than on men;
Amendment 147 #
Motion for a resolution
Paragraph 1 – point c
Paragraph 1 – point c
(c) to support civil society and women’s organisations that promote women’s rights, including women’s sexual and reproductive health and rights, and to work to ensure that women have a voice in European and national health policy issueies respond to their needs;
Amendment 219 #
Motion for a resolution
Paragraph 7
Paragraph 7
7. Underlines the fact that screening procedures are considered to be one ofin the early stages of cancer are considered, along with information programmes, to be among the most effective cancer prevention measures;
Amendment 230 #
Motion for a resolution
Paragraph 9 a (new)
Paragraph 9 a (new)
9a. Calls on Member States to ensure free access to health services for unemployed women, women in rural areas and women pensioners on low incomes, who cannot pay for medical checks and treatment themselves;
Amendment 257 #
Motion for a resolution
Paragraph 13
Paragraph 13
13. Calls on the Member States to take measurappropriate measures and allocate sufficient resources to ensure access to healthcare services – including women’s shelters – to all women, independent of their legal status, disability status, sexual orientation, race or ethnic origin, age or religion;
Amendment 266 #
Motion for a resolution
Paragraph 15
Paragraph 15
15. Supports a more markedly gender- sensitive approach to eating disorders and the need to mainstream it within the discourse on health and in information addressed to the general public;
Amendment 288 #
Motion for a resolution
Paragraph 19
Paragraph 19
19. Asks the Commission to incentivise projects at EU level focused on how women are treated in clinical research; such projects should involve health authorities at all levels and the pharmaceutical industry by way of the development of specific strategies for implementing the guidelines on studying and assessing gender differences in clinical trials;